Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06698159 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)

Study acronym: WIDER-PVI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 20, 2024 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The WIDER PVI study is a multicentre randomized clinical trial to compare the efficacy of antral versus extended antral PVI in patients with paroxysmal or persistent AF undergoing this procedure using a cryoablation balloon capable of 28 mm diameter (antral isolation) or 31 mm diameter (extended antral isolation) applications. The aim is to evaluate an objective of superiority of the extended antral isolation strategy versus antral isolation in the recurrence of atrial tachyarrhythmias at 1-year follow-up, both in episodes of \>30 seconds duration and in overall arrhythmic load.
Trial Details
NCT Number NCT06698159
Lead Sponsor Hospital Universitario 12 de Octubre
Conditions
(from sponsor)		 Atrial Fibrillation, Atrial Fibrillation (Paroxysmal)
Related terms Atrial Fibrillation
Enrollment 440 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov